Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Cat . Non | Espèces | Description du produit | Structure | Pureté | Caractéristique |
---|---|---|---|---|---|
CHEK-ATP126 | Human | HEK293/Human B7-H4 Stable Cell Line | |||
B74-M52H7 | Mouse | Azide-labeled Mouse B7-H4 Protein, His Tag (MALS verified) |
|
||
B74-C52H8 | Canine | Canine B7-H4 Protein, His Tag (MALS verified) |
|
||
B74-R52H9 | Rat | Rat B7-H4 Protein, His Tag |
|
||
B74-C52H9 | Cynomolgus / Rhesus macaque | Cynomolgus / Rhesus macaque B7-H4 Protein, His Tag (MALS verified) |
|
||
B74-M52H9 | Mouse | Mouse B7-H4 Protein, His Tag |
|
||
B74-H5256 | Human | Human B7-H4 Protein, Fc Tag, low endotoxin |
|
||
B74-H82E2 | Human | Biotinylated Human B7-H4 Protein, Avitag™,His Tag (recommended for biopanning) |
|
||
B74-H8222 | Human | Biotinylated Human B7-H4 Protein, His Tag, ultra sensitivity (primary amine labeling) (MALS verified) |
|
||
B74-H5222 | Human | Human B7-H4 Protein, His Tag (MALS verified) |
|
Expression analysis of human B7-H4 on HEK293/Human B7-H4 Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human B7-H4 Stable Cell Line or negative control cell using PE-labeled anti-human B7-H4 antibody.
Anti-B7-H4 antibody, Human IgG1 captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Canine B7-H4, His Tag (Cat. No. B74-C52H8) with an affinity constant of 8.59 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
GEN-1047 | GEN-1047 | Phase 2 Clinical | Genmab A/S | Carcinoma, Non-Small-Cell Lung | Details |
AZD-8205 | AZD-8205 | Phase 2 Clinical | Astrazeneca Plc | Ovarian Neoplasms; Biliary Tract Neoplasms; Solid tumours; Triple Negative Breast Neoplasms; Cholangiocarcinoma; Breast Neoplasms; Endometrial Neoplasms; Neoplasm Metastasis | Details |
HS-20089 | HS-20089 | Phase 2 Clinical | Shanghai Hansoh Biomedical Co Ltd | Ovarian Neoplasms; Solid tumours; Peritoneal Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms | Details |
Alsevalimab | FPA-150 | Phase 1 Clinical | Five Prime Therapeutics Inc | Ovarian Neoplasms; Solid tumours; Breast Neoplasms; Endometrial Neoplasms | Details |
ABL-103 | ABL-103 | Phase 1 Clinical | Abl Bio Inc, Handok Inc | Solid tumours | Details |
GSK-5733584 | GSK5733584; GSK-5733584 | Phase 1 Clinical | Glaxosmithkline Plc | Genital Neoplasms, Female | Details |
DB-1312 | BG-C9074; DB-1312 | Phase 1 Clinical | Solid tumours | Details | |
XKH-002 | XKH-002; XKH002 | Phase 1 Clinical | Beijing Kanova Biomedical Technology Co Ltd, Suzhou Kanova Biopharmaceutical Co Ltd | Solid tumours; Neoplasms | Details |
SGN-B7H4V | SGN-B7H4V; SGN-B-7H-4V; SGNB-7H4V; SGNB-7H-4V | Phase 1 Clinical | Ovarian Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Adenoid Cystic; Breast Neoplasms; Cholangiocarcinoma; Peritoneal Neoplasms; Endometrial Neoplasms; Gallbladder Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung | Details | |
XMT-1660 | XMT-1660 | Phase 1 Clinical | Mersana Therapeutics Inc | Ovarian Neoplasms; Abdominal Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Carcinoma, Adenoid Cystic; Breast Neoplasms; Fallopian Tube Neoplasms; Endometrial Neoplasms | Details |
HBM-7008 | HBM7008; HBM-7008; R-7008 | Phase 1 Clinical | Harbour Biomed | Solid tumours | Details |
This web search service is supported by Google Inc.